News

News Articles

1. Press releases, Kanvas Bio

   07, Nov, 2024

   Kan­vas Bio Unveils Clin­i­cal Data on the Gut Microbiome’s Impact on Anti-Tumoral Immu­ni­ty at SITC

2. Publications, Kanvas Bio

   07, Nov, 2024

   The gut micro­bio­me enhances anti-PD‑1 effi­ca­cy in a tumor-agnos­tic man­ner: results from a phase II tri­al of fecal micro­bio­ta trans­plan­ta­tion and anti-PD‑1 re-induc­tion in MSI‑H refrac­to­ry cancers

3. Interviews, Kanvas Bio

   16, Aug, 2024

   Wel­come, Drs. Mar­guerite Pri­or and Kevin Keomanee-Dizon!

4. External news, Forbes

   01, Jul, 2024

   This Biotech Start­up Raised $12.5 Mil­lion To Find Bac­te­ria That Help Fight Cancer

5. Press releases, Kanvas Bio

   01, Jul, 2024

   With $12.5M in New Fund­ing, Kan­vas Bio is Advanc­ing its Nov­el, Micro­bio­me-Based, Immuno-oncol­o­gy Drug Candidates

6. Press releases, Kanvas Bio

   21, Jun, 2024

   Intro­duc­ing the Next Drug Can­di­date in Kan­vas Bio’s Immuno-Oncol­o­gy Pro­gram: KAN-003

7. Interviews, The Economist

   17, Apr, 2024

   CEO Matt Cheng dis­cuss­es the micro­bio­me on The Econ­o­mist’s Bab­bage podcast

8. Interviews, Kanvas Bio

   15, Mar, 2024

   End­points News’ Ven­ture Invest­ing in Biotech Webi­nar Got Us Fired Up

9. External news, MedCity News

   29, Feb, 2024

   It’s Time to Evolve Beyond FMTs and Advance LBPs

10. Interviews, Kanvas Bio

    26, Jan, 2024

    Kan­vas Bio’s State of the Art AI Mod­els & Reflec­tions from JPM 2024